He returned to the U.S. with some of these psychoactive mushrooms, which he then sent to the Swiss chemist Albert Hoffman. Hoffman had previously been researching LSD and recognized and isolated the mushrooms’ Lively component, psilocybin.This Viewpoint examines how US states are reforming laws to permit entry to psychedelics for therapeutic use,